Doxofylline 400mgTablet
Respiratory

Doxofylline 400mg

Doxofylline

7-dioxolane derivative xanthine bronchodilator offering comparable bronchodilation to theophylline but with substantially lower phosphodiesterase inhibition at cardiac and GI receptor sites, resulting in improved GI and cardiovascular tolerability. Therapeutic drug monitoring is generally not required, simplifying clinical management in COPD and asthma patients.

Strengths

200mg / 400mg

Packing

10 tablets/strip

Origin

India (WHO-GMP)

MOQ

100 units

Export Price

On Request

Availability

In Stock

Quotation with pricing, availability, and shipping timeline sent within 24 hours.

Product Specifications

Composition
Doxofylline 200mg / 400mg
Dosage Form
Tablet
Available Strengths
200mg / 400mg
Packing
10 tablets/strip
Route of Administration
Oral, with or without food
Dosage
400mg twice daily or three times daily; maximum 1200mg/day; may be titrated based on response
Indications
Chronic obstructive pulmonary disease, bronchial asthma, obstructive bronchitis — as bronchodilator and anti-inflammatory
Country of Origin
India (WHO-GMP Certified)
Storage
Store at 25°C, protected from moisture
Shelf Life
36 months
Side Effects
Nausea, GI discomfort, headache, palpitations, insomnia (significantly less than theophylline); rarely arrhythmias
Precautions
Better tolerability profile than theophylline; fewer drug interactions; caution in peptic ulcer disease; TDM generally not required; caution in cardiac disease

Disclaimer: This information is intended for healthcare professionals and international pharmaceutical buyers only. Product availability, registration status, and approved indications may vary by country. All products are supplied with Certificate of Analysis (CoA), commercial invoice, and packing list. Rx products require valid prescription in the destination country.

Need bulk pricing for Doxofylline 400mg?

Send us your quantity requirements and destination country for a custom quotation.

Get Bulk Quote